Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20190721044285N1Phase 3Completed
Phase 3, randomised trial in None comparing Ephedrine + atracurium, Ketamine + atracurium and Placebo + atracurium (3 arms). Primary endpoint: Onset time of atracurium. Started Aug 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20190721044285N1.